Colleen Bass, WHNP, CNM | |
4-1558 Kuhio Highway, Kapaa, HI 96746 | |
(808) 631-2682 | |
(866) 423-3332 |
Full Name | Colleen Bass |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 4-1558 Kuhio Highway, Kapaa, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336413814 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | APRN1437 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Colleen Bass, WHNP, CNM 4-1558 Kuhio Highway, Kapaa, HI 96746 Ph: (808) 631-2682 | Colleen Bass, WHNP, CNM 4-1558 Kuhio Highway, Kapaa, HI 96746 Ph: (808) 631-2682 |
News Archive
For more than 125 years, the American Dental Association (ADA) has been evaluating dental products for safety and effectiveness. The ADA Seal of Acceptance, which is a registered certification mark, is awarded after a product is tested and meets ADA guidelines and standards. The Pennsylvania Dental Association encourages you to shop wisely and purchase dental care products with the ADA Seal.
Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today announced the start of its "Patient First" project as part of the Year of Affordable Healthcare campaign. The initiative, available at: www.yearofaffordablehealth.com/patients, features a first-hand perspective of everyday Americans as they struggle with the enormous and sometimes insurmountable expense of paying for their prescription medicines.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
Gerresheimer AG, one of the leading global suppliers to the pharma and healthcare industry, got off to a good start in the new financial year. "We continued on our successful course in the new financial year.
Medical International Technology Inc. is pleased to announce its progress in China. Based on the results obtained in two separate pivotal clinical trials over the past six months, the Chinese SFDA authorities have approved and issued to our Joint Venture Corporation the official licence to sell MED-JET products.
› Verified 9 days ago